Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components
Clinical trial NCT04895059 · COMPLETED
Trial details
- NCT number
- NCT04895059
- Sponsor
- Laboratorios Silanes S.A. de C.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-30
- Primary completion
- 2018-01-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.